← Browse by Condition
Medical Condition

osteoarthritis

Total Trials
15
Recruiting Now
15
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for osteoarthritis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — osteoarthritis Clinical Trials

How many clinical trials are currently recruiting for osteoarthritis?
ClinicalMetric currently tracks 15 actively recruiting clinical trials for osteoarthritis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 15. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for osteoarthritis?
osteoarthritis research spans Phase 2 (3 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a osteoarthritis clinical trial?
Eligibility criteria for osteoarthritis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
3
Phase 3
2
Top Sponsors
DePuy Orthopaedics 1 trial
Fonds de Dotation pour la Recherche Clinique en Orthopédie et Pathologie du Sport 1 trial
Grigory Karmy 1 trial
University of British Columbia 1 trial
University of Florida 1 trial

Recruiting Clinical Trials

NCT06631638
Recruiting
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
Enrollment
118 pts
Location
United States
Sponsor
DePuy Orthopaedics
View Trial →
NCT02511158
Recruiting
French Prospective Anterior Cruciate Ligament Reconstruction Cohort Study (FAST)
Enrollment
7,000 pts
Location
France
Sponsor
Fonds de Dotation pour la Rech...
View Trial →
NCT05507099 Phase 2
Recruiting
Stem Cell Study in Osteoarthritis of the Knee and Hip Joints
Enrollment
400 pts
Location
Canada
Sponsor
Grigory Karmy
View Trial →
NCT07069179
Recruiting
Feasibility of Choose to Move Replacement Ready
Enrollment
60 pts
Location
Canada
Sponsor
University of British Columbia
View Trial →
NCT00411060
Recruiting
Clinical Orthopaedic Data Bank (Acute and Chronic)
Enrollment
10,000 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT05912153
Recruiting
SPECT-CT vs MRI for the Diagnosis of Osteoarthritis in the Foot and Ankle
Enrollment
132 pts
Location
Netherlands
Sponsor
Martini Hospital Groningen
View Trial →
NCT02844764 Phase 2
Recruiting
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip
Enrollment
4,000 pts
Location
United States
Sponsor
VivaTech International, Inc.
View Trial →
NCT07324746
Recruiting
The Effectiveness of a Herbal Supplement in Osteoarthritis.
Enrollment
30 pts
Location
United Kingdom
Sponsor
Middlesex University
View Trial →
NCT06485843 Phase 2
Recruiting
An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint
Enrollment
400 pts
Location
United States
Sponsor
Ageless Biotech, Inc.
View Trial →
NCT06805188
Recruiting
Clinical Study of Acupuncture Treatment of Knee Osteoarthritis
Enrollment
350 pts
Location
China
Sponsor
Wu zenan
View Trial →
NCT06932887 Phase 3
Recruiting
The Beat Pain Better Trial
Enrollment
346 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT06896032
Recruiting
Retro-walking Versus Forward-walking Training Using Underwater Treadmill in Patients With Knee Osteoarthritis
Enrollment
60 pts
Location
Egypt
Sponsor
Nourhan Atwa Said
View Trial →
NCT07473414
Recruiting
Synovial Tissue as a Biomarker in the Early Management of Osteoarthritis
Enrollment
30 pts
Location
France
Sponsor
Nantes University Hospital
View Trial →
NCT07301892
Recruiting
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
Enrollment
100 pts
Location
China
Sponsor
Guang'anmen Hospital of China ...
View Trial →
NCT07353931 Phase 3
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Enrollment
900 pts
Location
United States, Argen...
Sponsor
Eli Lilly and Company
View Trial →

Related Conditions

osteoarthritis oa of the knee (3) traumatic arthritis (1) rheumatoid arthritis (1) congential hip dysplasia (1) avascular necrosis of the femoral head (1) certain cases of ankylosis (1) rupture of anterior cruciate ligament (1) osteoarthritis hip (1) total knee arthroplasty total hip arthroplasty (1) mobility limitation (1) social isolation or loneliness (1) pain (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology